
GeoVax Forms Oncology Advisory Board to Guide Gedeptin® Development in Solid Tumors
GeoVax Labs has established an Oncology Advisory Board with three leading experts to advance its Gedeptin® therapy through combination trials with immune checkpoint inhibitors, potentially enhancing treatment for solid tumors like head and neck cancer.
Read full story






















